References
- Taylor DA, Atkins BZ, Hungspreugs P et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929— 33.
- Reinlib L, Field L. Cell transplantation as future therapy for cardiovascular disease? A workshop of the national Heart, Lung, and Blood Institute. Circulation 2000;101:E182— 7.
- Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369 — 77.
- Goodell MA, Jackson KA, Majka SM et al. Stem cell plasticity inmuscle and bone marrow. Ann NY Acad Sci 2001;938:208–18.
- Tomita S, Li RK, Weisel RD, et al. Autologus transplantation ofbone marrow cells improves damaged heart function. Circulation 1999;100(19 suppl):II247–11256.
- Yang R, Thomas GR, Bunting S et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. 7 Cardiovasc Pharmacol 1996;2 7:8 3 8 — 44.
- Nidorf SM, Siu SC, Galamobs G et al. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. Y Am Coll Cardiol 1993;21:683–91.
- Melillo G, Scoccianti M, Kovesdi I et al. Gene therapy for collateral vessel development. Cardiovasc Res 1997;35:480–9.
- Losordo DW, Vale PR, Symes JF et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998;98:2800–4.
- US National Institutes of Health. Revised Guide fir the Care andUse of Laboratoly Animals. NIH publication No. 85–23. NIH Guide 1996;25:34. National Institutes of Health, 1996.
- Freedman SB, Isner IM. The therapeutic angiogenesis for ischemic cardiovascular disease. 7 Mol Cell Cardiol 2001;33: 379— 93.
- Iwaguro H, Yamagushi JI, Kalka C et al. Endothelial progenitorcell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732— 8.
- Yeh ETH. Life and death in the cardiovascular system. Circulation 1997;95:782–6.
- Jiang Y, Jahagirdar B, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41–9.
- Terada N, Hamazaki T, Oka M et al. Bone marrow cells adoptthe phenotype of other cells by spontaneous cell fusion. Nature 2002;416:542–5.
- Ying QL, Nichols J, Evans EP, Smith AG. Changing potency byspontaneous fusion. Nature 2002;416:545— 8.
- Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerate liver by cell fusion. Nature 2003;422:901–4.
- Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003;422:897— 901.
- Lagasse E, Connors H, Al-Dhalimy M et al. Purified hemato-poietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000;6:1229— 34.
- Srivatsa B, Srivatsa S, Johnson KL et al. Microchimerism of presumed fetal origion in thyroid specimens from women: a case-control study. Lancet 2001;358:2034–8.
- Korbling M, Katz RL, Khanna A et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl 7 Med 2002;346:738–46.
- Deb A, Wang SH, Skelding KA et al. Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Cir-culation 2003;107:1247–9.
- Kocher AA, Schuster MD, Szaboles MI et al. Neovascularizationof ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodel-ing and improves cardiac function. Nat Med 2001;7:430–6.